GleanMark

BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE. Trademark

BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE. is a USPTO trademark filed by Millennium Pharmaceuticals, Inc.. Status: Cancelled.

Trademark Facts

MarkBREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.
Serial Number78171952
Registration Number3030017
StatusCancelled
Filing Date2002-10-07
Registration Date2005-12-13
Mark TypeWord
Nice Classes042 (Software & IT), 044 (Medical Services)
OwnerMillennium Pharmaceuticals, Inc.
Attorney of RecordMichael J. Bevilacqua, Esquire
Prosecution Events49
Latest Event1000 on 2012-07-20

Goods & Services

Class 042: RESEARCH SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS AND PRODUCT DEVELOPMENT SERVICES IN THE BIOMEDICAL, GENOMIC PHARMACOGENOMIC, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; RESEARCH CONSULTING SERVICES, NAMELY, RESEARCH, DEVELOPMENT, VALIDATION, TESTING, DATA ANALYSIS, AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS IN THE BIOMEDICAL, GENOMIC, PHARMACEUTICAL, PHARMACOGENOMICS, DIAGNOSTIC, CLINICAL TRIAL DESIGN, AND BIOTECHNOLOGY FIELDS; CONSULTATION SERVICES, NAMELY, PROVIDING CONSULTATION TO OTHERS VIA GLOBAL, NATIONAL, AND LOCAL COMPUTER NETWORKS IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY; PROVIDING ON-LINE COMPUTER DATABASES VIA GLOBAL, NATIONAL, AND LOCAL IN THE FIELDS OF LIFE SCIENCES, PHARMACOGENOMICS, DIAGNOSTICS, CLINICAL TRIAL DESIGN AND BIOTECHNOLOGY; Class 044: MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENT BASED ON GENE AND PROTEIN EXPRESSION AND/OR ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS

Related